Literature DB >> 9327742

Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1.

D B Landry1, L L Couper, S R Bryant, V Lindner.   

Abstract

The NF-kappa B transcription factor family and its inhibitory proteins (I kappa B) form an autoregulatory system that has been linked to endothelial gene expression and vascular disease. To determine the role of the NF-kappa B/I kappa B system in smooth muscle cells (SMCs) in vivo, the present study used the balloon catheter injury model in the rat carotid artery. The NF-kappa B family members p50, p65, p52, c-Rel, and RelB as well as the inhibitor proteins I kappa B alpha, I kappa B beta, and p105 were present in uninjured arteries as determined by immunoblotting. Using electromobility shift assays, low levels of constitutively activated p50, p65, and c-Rel were seen in normal carotid arteries and a fivefold induction occurred during times of rapid SMC proliferation and neointima formation after balloon denudation. Furthermore, immediately after injury, the levels of I kappa B alpha, I kappa B beta, and p105 were dramatically reduced. Expression of the NF-kappa B-regulated genes, vascular cell adhesion molecule (VCAM)-1 and monocyte chemotactic protein (MCP)-1, was apparent in SMCs within 4 hours after injury. Macrophage infiltration occurred in parallel with the expression of VCAM-1 and MCP-1, and these inflammatory cells were present on the luminal surface of injured vessels during intimal lesion formation. In chronically denuded vessels, the SMCs on the luminal surface continued to express high levels of VCAM-1 and MCP-1, which may account for the increased presence of macrophages. Together, these findings link the activation of NF-kappa B to intimal lesion formation and to the inflammatory response associated with SMCs after vascular injury.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9327742      PMCID: PMC1858027     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

Review 1.  Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system.

Authors:  H C Liou; D Baltimore
Journal:  Curr Opin Cell Biol       Date:  1993-06       Impact factor: 8.382

2.  Vascular smooth muscle cells express a constitutive NF-kappa B-like activity.

Authors:  R Lawrence; L J Chang; U Siebenlist; P Bressler; G E Sonenshein
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

3.  Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines.

Authors:  S Miyamoto; P J Chiao; I M Verma
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

4.  Distinct NF-kappa B/Rel transcription factors are responsible for tissue-specific and inducible gene activation.

Authors:  T Lernbecher; U Müller; T Wirth
Journal:  Nature       Date:  1993-10-21       Impact factor: 49.962

5.  Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma.

Authors:  H Li; M I Cybulsky; M A Gimbrone; P Libby
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

6.  The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms.

Authors:  M L Scott; T Fujita; H C Liou; G P Nolan; D Baltimore
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

7.  Fibronectin attachment activates the NF-kappa B p50/p65 heterodimer in fibroblasts and smooth muscle cells.

Authors:  E E Qwarnström; C O Ostberg; G L Turk; C A Richardson; K Bomsztyk
Journal:  J Biol Chem       Date:  1994-12-09       Impact factor: 5.157

8.  Involvement of NF-kappa B activation in thrombin-induced human vascular smooth muscle cell proliferation.

Authors:  T Nakajima; I Kitajima; H Shin; I Takasaki; K Shigeta; K Abeyama; Y Yamashita; T Tokioka; Y Soejima; I Maruyama
Journal:  Biochem Biophys Res Commun       Date:  1994-10-28       Impact factor: 3.575

9.  NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation.

Authors:  M A Read; M Z Whitley; A J Williams; T Collins
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

10.  Functional analysis of the human vascular cell adhesion molecule 1 promoter.

Authors:  A S Neish; A J Williams; H J Palmer; M Z Whitley; T Collins
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  42 in total

Review 1.  Gene therapy for restenosis.

Authors:  R C Smith; K Walsh
Journal:  Curr Cardiol Rep       Date:  2000-01       Impact factor: 2.931

2.  miR-146a mediates thymosin β4 induced neurovascular remodeling of diabetic peripheral neuropathy in type-II diabetic mice.

Authors:  Lei Wang; Michael Chopp; XueRong Lu; Alexandra Szalad; LongFei Jia; Xian Shuang Liu; Kuan-Han Wu; Mei Lu; Zheng Gang Zhang
Journal:  Brain Res       Date:  2018-11-27       Impact factor: 3.252

Review 3.  Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis.

Authors:  Anthony Wayne Orr; Nicole E Hastings; Brett R Blackman; Brian R Wamhoff
Journal:  J Vasc Res       Date:  2009-10-22       Impact factor: 1.934

4.  Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression.

Authors:  Eleni Tzima; Miguel Angel Del Pozo; William B Kiosses; Samih A Mohamed; Song Li; Shu Chien; Martin Alexander Schwartz
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

5.  The integrin alpha2beta1 agonist, aggretin, promotes proliferation and migration of VSMC through NF-kB translocation and PDGF production.

Authors:  Ching-Hu Chung; Kuan-Ting Lin; Chien-Hsin Chang; Hui-Chin Peng; Tur-Fu Huang
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

Review 6.  Inflammation, immunity, and hypertensive end-organ damage.

Authors:  William G McMaster; Annet Kirabo; Meena S Madhur; David G Harrison
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

7.  Baicalein attenuates intimal hyperplasia after rat carotid balloon injury through arresting cell-cycle progression and inhibiting ERK, Akt, and NF-kappaB activity in vascular smooth-muscle cells.

Authors:  Chieh-Yu Peng; Shiow-Lin Pan; Ying-Wen Huang; Jih-Hwa Guh; Ya-Ling Chang; Che-Ming Teng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-29       Impact factor: 3.000

8.  Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells.

Authors:  Shankar Mukherjee; Huan Huang; Stefka B Petkova; Chris Albanese; Richard G Pestell; Vicki L Braunstein; George J Christ; Murray Wittner; Michael P Lisanti; Joan W Berman; Louis M Weiss; Herbert B Tanowitz
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 9.  Oxidative stress as a mediator of cardiovascular disease.

Authors:  Maqsood M Elahi; Yu Xiang Kong; Bashir M Matata
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

10.  In vitro photodynamic therapy with chlorin e6 leads to apoptosis of human vascular smooth muscle cells.

Authors:  Magdalena Wawrzyńska; Wojciech Kałas; Dariusz Biały; Ewa Zioło; Jacek Arkowski; Walentyna Mazurek; Leon Strzadała
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-02       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.